Top Stories
- Immunize.org asks for your feedback once every 2 years! Please take 5 minutes to make your voice heard.
- Immunize.org reviews and updates “Ask the Experts: Vaccine Recommendations,” adding resources for professional medical organizations’ recommendations and schedules
- Live-virus chikungunya vaccine (Ixchiq, Valneva) withdrawn from the U.S. market. Non-live chikungunya vaccine (Vimkunya, Bavarian Nordic) is recommended when chikungunya protection is needed.
- After January 31, most regions of the United States may pause RSV vaccination during pregnancy. Keep giving RSV preventive antibody to all susceptible infants through March.
- Measles 2026: South Carolina outbreak growing fast, more than 400 confirmed cases in 14 states since January 1
- Respiratory viruses are still spreading across the country; keep encouraging vaccination
- “What Is the Burden of Influenza Disease in the United States?” Watch the 3-minute answer, part of the Ask the Experts Video Series on YouTube.
- Vaccines in the news
Immunize.org Website and Clinical Resources
Notable Publications
- “Vaccinations Among Adults Age 65 and Older: United States, 2024” published by CDC’s National Center for Health Statistics
- Commentary: “A Risk to Child Health: Confusion and Concern over Changes to US Vaccine Policy” published in Lancet
- “High-Dose vs Standard-Dose Influenza Vaccine in Older Adults with Diabetes” published in JAMA
Upcoming Events
- Virtual: Hepatitis B Foundation hosts webinars on HepB birth dose on February 3 and 12
- Virtual: Register for Immunize.org Website Office Hours. Join a 30-minute discussion about our new Official Guidance: Healthcare Professional Organization Schedules content on February 11 at 4:00 p.m. (ET) or February 12 at 12:00 p.m. (ET). Recorded sessions are archived.